What is Andersons Inc/The's earnings per share (EPS)?

Andersons Inc/The (ANDE) reported diluted earnings per share of $2.79 for fiscal year 2025. This represents a -16.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Andersons Inc/The (ANDE) Financials

ANDE

Trailing 12 months to June 30, 2026

Revenue $10.9B -5.2% YoY

Net Income $177.3M +120.0% YoY

EPS (Diluted) $2.79 FY2025 annual

Free Cash Flow $56.9M +112.2% YoY

Market Cap $2.2B as of Oct 17, 2026

Price / Sales 0.2x on $10.9B revenue, trailing 12 months to June 30, 2026

Price / Earnings 12.4x on $177.3M net income, trailing 12 months to June 30, 2026

Price / Book 1.7x on $1.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ANDE SEC filings page.

Andersons Inc/The (ANDE) reported $10.9B in revenue over the twelve months to Jun 30, 2026, down 5.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ANDE FY2025 2026-10-03

Margins improved despite shrinking sales, but FY2025 shows weaker cash conversion and heavier reinvestment.

Operating cash flow fell from $946.8M in FY2023 to $177.0M in FY2025 while net income remained positive, weakening earnings-to-cash conversion. Because FY2025 capital expenditures reached $233.1M, free cash flow was -$56.1M; the latest profit therefore did not fund reinvestment internally.

Despite lower sales after FY2022, gross margin rose from 3.95% to 6.48%, indicating better gross economics without volume growth. Net margin then slipped from 1.0% to 0.9% in FY2025, so that improvement was partly absorbed below gross profit rather than fully reaching the bottom line.

Working capital is inventory-heavy: inventory was $1.4B against current assets of $2.4B in FY2025. The current ratio fell from 1.7x in FY2023 to 1.4x in FY2025, while debt-to-equity stayed near 0.4x, pointing to tighter short-term liquidity without a major leverage shift.

Financial Health Signals

Financial Health Score 23/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Andersons Inc/The's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Not available for Andersons Inc/The, and counted as zero in the overall score.

Growth

Andersons Inc/The's revenue declined 2.2% year-over-year, from $11.3B to $11.0B. This contraction results in a growth score of 7/100.

Leverage

Andersons Inc/The has a moderate D/E ratio of 0.45. This balance of debt and equity financing earns a leverage score of 63/100.

Liquidity

Andersons Inc/The's current ratio of 1.41 indicates adequate short-term liquidity, earning a score of 38/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Andersons Inc/The generated $177.0M in operating cash flow, capex of $233.1M consumed most of it, leaving -$56.1M in free cash flow. This results in a low score of 30/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Not available for Andersons Inc/The, and counted as zero in the overall score.

Piotroski F-Score Neutral

6/9

Andersons Inc/The passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

1.85x

For every $1 of reported earnings, Andersons Inc/The generates $1.85 in operating cash flow ($177.0M OCF vs $95.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.1B

YoY-1.2%

QoQ+17.9%

5Y CAGR-0.9%

10Y CAGR+11.3%

Andersons Inc/The generated $3.1B in revenue in Q2 2026. This represents a decrease of 1.2% from the same quarter a year earlier. Against the prior quarter it is up 17.9%.

Net Income

$56.6M

YoY+619.9%

QoQ+70.4%

5Y CAGR+5.4%

10Y CAGR+14.6%

Andersons Inc/The reported $56.6M in net income in Q2 2026. This represents an increase of 619.9% from the same quarter a year earlier. Against the prior quarter it is up 70.4%.

EPS (Diluted)

$1.65

YoY+617.4%

QoQ+70.1%

Andersons Inc/The earned $1.65 per diluted share (EPS) in Q2 2026. This represents an increase of 617.4% from the same quarter a year earlier. Against the prior quarter it is up 70.1%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow

$412.4M

YoY+64.6%

QoQ+192.6%

5Y CAGR+17.7%

10Y CAGR+23.2%

Andersons Inc/The generated $412.4M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 64.6% from the same quarter a year earlier. Against the prior quarter it is up 192.6%.

Cash & Debt

$66.5M

YoY-81.0%

QoQ-8.1%

5Y CAGR+19.3%

10Y CAGR+7.8%

Andersons Inc/The held $66.5M in cash against $563.5M in long-term debt as of Q2 2026.

Dividends Per Share

$0.20

YoY+2.6%

QoQ0.0%

5Y CAGR+2.7%

10Y CAGR+2.6%

Andersons Inc/The paid $0.20 per share in dividends in Q2 2026. This represents an increase of 2.6% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

34M

YoY-0.7%

QoQ-0.2%

5Y CAGR+0.4%

10Y CAGR+1.9%

Andersons Inc/The had 34M shares outstanding in Q2 2026. This represents a decrease of 0.7% from the same quarter a year earlier. Against the prior quarter it is down 0.2%.

Margins & Returns

Gross Margin

7.2%

YoY+2.2pp

QoQ+1.1pp

Andersons Inc/The's gross margin was 7.2% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Net Margin

1.8%

YoY+1.6pp

QoQ+0.6pp

5Y change+0.5pp

10Y change+0.5pp

Andersons Inc/The's net profit margin was 1.8% in Q2 2026, showing the share of revenue converted to profit. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Return on Equity

4.3%

YoY+3.7pp

QoQ+1.7pp

5Y change0.0pp

10Y change+2.4pp

Andersons Inc/The's ROE was 4.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 3.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Capital Expenditures

$75.6M

YoY+54.8%

QoQ+46.1%

5Y CAGR+34.2%

10Y CAGR+13.1%

Andersons Inc/The invested $75.6M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 54.8% from the same quarter a year earlier. Against the prior quarter it is up 46.1%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

ANDE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ANDE quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$10.9B	$11.0B-2.2%	$11.3B-23.7%	$14.8B-14.9%	$17.3B+37.4%	$12.6B+56.4%	$8.1B+0.8%	$8.0B+162.8%	$3.0B-17.4%	$3.7B-6.1%	$3.9B-6.5%	$4.2B-7.5%	$4.5B-19.0%	$5.6B+6.3%	$5.3B+15.2%	$4.6B
Cost of Revenue	$10.2B	$10.3B-2.5%	$10.6B-24.6%	$14.0B-15.8%	$16.6B+38.5%	$12.0B+56.1%	$7.7B+2.1%	$7.5B+174.9%	$2.7B-18.5%	$3.4B-5.9%	$3.6B-6.4%	$3.8B-7.7%	$4.1B-20.9%	$5.2B+6.6%	$4.9B+16.3%	$4.2B
Gross Profit	$786.7M	$713.7M+2.8%	$693.9M-6.9%	$745.4M+8.9%	$684.2M+15.4%	$592.7M+61.9%	$366.2M-20.5%	$460.8M+52.6%	$302.0M-5.3%	$318.8M-7.7%	$345.5M-8.1%	$375.8M-5.4%	$397.1M+8.7%	$365.2M+2.0%	$358.0M+1.5%	$352.9M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$1.0M+25.0%	$800K
Interest Expense	-$55.0M	-$47.2M-48.5%	-$31.8M+32.2%	-$46.9M+17.6%	-$56.8M-52.4%	-$37.3M-10.4%	-$33.8M+21.8%	-$43.2M-55.1%	-$27.8M-29.1%	-$21.6M-2.1%	-$21.1M-5.2%	-$20.1M+7.8%	-$21.8M-195.0%	$22.9M+5.5%	$21.7M-13.9%	$25.2M
Income Tax	$34.2M	$22.2M-26.2%	$30.1M-18.8%	$37.0M-6.5%	$39.6M+35.6%	$29.2M+367.9%	-$10.9M-219.3%	$9.1M-23.4%	$11.9M+118.9%	-$63.1M-1013.5%	$6.9M+2955.8%	-$242K-100.4%	$61.5M+14.3%	$53.8M+20.7%	$44.6M-12.7%	$51.1M
Net Income	$177.3M	$95.7M-16.1%	$114.0M+12.7%	$101.2M-22.8%	$131.1M+26.1%	$104.0M+1248.7%	$7.7M-57.9%	$18.3M-55.9%	$41.5M-2.4%	$42.5M+266.7%	$11.6M+188.7%	-$13.1M-111.9%	$109.7M+22.0%	$89.9M+13.2%	$79.5M-16.4%	$95.1M
EPS (Basic)	N/A	$2.81-16.1%	$3.35+11.7%	$3.00-22.9%	$3.89+24.7%	$3.12+1256.5%	$0.23-58.9%	$0.56-61.9%	$1.47-2.6%	$1.51+268.3%	$0.41+189.1%	-$0.46-111.9%	$3.85+20.3%	$3.20+12.3%	$2.85-16.7%	$3.42
EPS (Diluted)	—	$2.79-16.0%	$3.32+12.9%	$2.94-22.8%	$3.81+24.1%	$3.07+1234.8%	$0.23-58.2%	$0.55-62.3%	$1.46-2.7%	$1.50+265.9%	$0.41+189.1%	-$0.46-112.0%	$3.84+20.8%	$3.18+12.8%	$2.82-16.8%	$3.39
Diluted Shares (Avg)	N/A	34M0.0%	34M-0.2%	34M-0.1%	34M+1.7%	34M+2.0%	33M+0.3%	33M+16.3%	28M+0.6%	28M-0.5%	28M+0.5%	28M-0.6%	28M+0.9%	28M+0.5%	28M+0.4%	28M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$3.1B-1.2%	$2.6B-1.2%	$2.5B-18.8%	$2.7B+2.2%	$3.1B+12.2%	$2.7B-2.2%	$3.1B-2.8%	$2.6B-27.9%
Cost of Revenue	$2.9B-3.5%	$2.5B-1.6%	$2.3B-20.8%	$2.5B+2.6%	$3.0B+13.7%	$2.5B-3.2%	$2.9B-2.8%	$2.4B-29.7%
Gross Profit	$223.7M+41.2%	$160.6M+5.0%	$231.5M+8.6%	$170.9M-3.5%	$158.4M-9.7%	$152.9M+19.1%	$213.1M-2.1%	$177.1M+12.3%
Interest Expense	-$15.6M-36.1%	-$16.8M-28.6%	-$12.1M-17.8%	-$10.5M-25.3%	-$11.5M-73.9%	-$13.1M-100.8%	-$10.3M-26.7%	-$8.4M-2.1%
Income Tax	$13.4M+66.8%	$4.6M+315.3%	$16.5M+25.4%	-$228K-102.1%	$8.0M+64.6%	-$2.1M-262.5%	$13.1M-1.3%	$10.7M+36.5%
Net Income	$56.6M+619.9%	$33.2M+11585.9%	$67.4M+49.6%	$20.1M-26.4%	$7.9M-78.2%	$284K-94.9%	$45.1M-11.9%	$27.4M+181.9%
EPS (Basic)	$1.66+621.7%	$0.98+9700.0%	N/A	$0.59-26.3%	$0.23-78.3%	$0.01-93.8%	$1.32-13.2%	$0.80+175.9%
EPS (Diluted)	$1.65+617.4%	$0.97+9600.0%	N/A	$0.59-26.3%	$0.23-78.1%	$0.01-93.8%	$1.31-11.5%	$0.80+185.7%
Diluted Shares (Avg)	34M-0.1%	34M-0.5%	N/A	34M-0.5%	34M-0.1%	34M+0.2%	N/A	34M+0.3%

Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

ANDE Balance Sheet

ANDE quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$3.7B-9.9%	$4.1B+6.9%	$3.9B-16.3%	$4.6B+0.8%	$4.6B+7.0%	$4.3B+9.5%	$3.9B+63.1%	$2.4B+10.6%	$2.2B-3.2%	$2.2B-5.4%	$2.4B-0.2%	$2.4B+4.0%	$2.3B+4.2%	$2.2B+25.8%	$1.7B
Current Assets	$2.4B-16.6%	$2.9B+1.5%	$2.8B-19.0%	$3.5B+2.8%	$3.4B+39.6%	$2.4B+24.2%	$1.9B+90.1%	$1.0B+2.4%	$999.2M-5.6%	$1.1B-6.3%	$1.1B-10.0%	$1.3B+2.7%	$1.2B-5.8%	$1.3B+17.2%	$1.1B
Cash & Equivalents	$98.3M-82.5%	$561.8M-12.7%	$643.9M+458.6%	$115.3M-46.7%	$216.4M+643.2%	$29.1M-46.9%	$54.9M+143.0%	$22.6M-35.3%	$34.9M-44.2%	$62.6M-1.8%	$63.8M-44.4%	$114.7M-62.9%	$309.1M+123.6%	$138.2M+577.9%	$20.4M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$1.4B+6.1%	$1.3B+10.3%	$1.2B-32.6%	$1.7B-4.6%	$1.8B+40.3%	$1.3B+10.5%	$1.2B+69.4%	$690.8M+6.5%	$648.7M-5.0%	$682.7M-8.7%	$747.4M-6.1%	$795.7M+29.4%	$614.9M-20.8%	$776.7M+2.1%	$760.5M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$127.9M0.0%	$127.9M0.0%	$127.9M-1.1%	$129.3M0.0%	$129.3M-1.7%	$131.5M+0.3%	$131.2M+6964.8%	$1.9M-69.2%	$6.0M-90.6%	$63.9M0.0%	$63.9M-11.7%	$72.4M+23.6%	$58.6M+7.7%	$54.4M+333.5%	$12.5M
Total Liabilities	$2.4B-3.9%	$2.5B+7.8%	$2.3B-26.4%	$3.2B-2.6%	$3.3B+4.8%	$3.1B+15.0%	$2.7B+78.5%	$1.5B+13.1%	$1.3B-7.1%	$1.4B-8.5%	$1.6B+2.3%	$1.5B-0.5%	$1.5B-1.4%	$1.6B+31.4%	$1.2B
Current Liabilities	$1.7B-2.6%	$1.7B+5.8%	$1.6B-35.1%	$2.5B+2.3%	$2.5B+27.6%	$1.9B+34.2%	$1.4B+72.8%	$833.4M+12.8%	$738.7M-7.6%	$799.8M-9.9%	$888.0M-13.6%	$1.0B+3.6%	$992.3M0.0%	$992.8M+25.0%	$794.3M
Non-Current Liabilities	$736.2M-6.8%	$790.3M+12.5%	$702.3M+6.9%	$656.9M-17.6%	$797.6M-32.4%	$1.2B-6.7%	$1.3B+85.5%	$681.9M+13.5%	$600.7M-6.5%	$642.4M-6.5%	$687.3M+34.0%	$512.9M-7.9%	$556.8M-3.7%	$578.1M+44.1%	$401.0M
Long-Term Debt	$560.0M-7.9%	$608.2M+8.0%	$563.0M+14.3%	$492.5M-18.0%	$600.5M-32.3%	$886.5M-12.8%	$1.0B+104.8%	$496.2M+18.6%	$418.3M+5.4%	$397.1M-9.0%	$436.2M+46.1%	$298.6M-20.4%	$375.2M-12.2%	$427.2M+78.8%	$238.9M
Total Equity	$1.2B-8.9%	$1.4B+6.5%	$1.3B+7.0%	$1.2B+11.8%	$1.1B+11.5%	$961.9M-1.2%	$973.6M+17.3%	$830.3M+1.9%	$815.2M+5.3%	$774.4M+1.3%	$764.3M-4.8%	$803.1M+14.5%	$701.5M+18.0%	$594.4M+13.4%	$524.0M
Retained Earnings	$1.0B+7.0%	$970.7M+9.9%	$882.9M+9.3%	$807.8M+14.9%	$702.8M+12.2%	$626.1M-2.6%	$642.7M-0.7%	$647.5M+2.2%	$633.5M+4.0%	$609.2M-1.0%	$615.2M-4.6%	$644.6M+17.5%	$548.4M+16.5%	$470.6M+16.9%	$402.5M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$3.5B+0.8%	$3.9B+3.2%	$3.7B-9.9%	$3.3B-2.7%	$3.4B+4.4%	$3.8B+16.5%	$4.1B+6.9%	$3.4B-5.6%
Current Assets	$2.1B-4.3%	$2.6B+1.1%	$2.4B-16.6%	$2.0B-15.9%	$2.2B-3.3%	$2.5B+14.2%	$2.9B+1.5%	$2.3B-7.8%
Cash & Equivalents	$66.5M-81.0%	$72.4M-67.0%	$98.3M-82.5%	$81.6M-82.0%	$351.0M-33.8%	$219.2M-22.8%	$561.8M-12.7%	$454.1M+8.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$961.0M+24.5%	$1.4B+12.0%	$1.4B+6.1%	$899.3M+1.7%	$771.9M+12.4%	$1.2B+25.6%	$1.3B+10.3%	$884.3M-10.2%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$127.9M0.0%	N/A	N/A	N/A	$127.9M0.0%	N/A
Total Liabilities	$2.1B+15.3%	$2.6B+18.5%	$2.4B-3.9%	$2.1B+11.2%	$1.8B+3.2%	$2.2B+23.4%	$2.5B+7.8%	$1.9B-12.8%
Current Liabilities	$1.4B+27.6%	$1.9B+30.4%	$1.7B-2.6%	$1.3B+13.0%	$1.1B-0.4%	$1.4B+32.4%	$1.7B+5.8%	$1.2B-16.3%
Non-Current Liabilities	$737.6M-2.4%	$739.7M-3.8%	$736.2M-6.8%	$743.5M+8.2%	$755.4M+8.7%	$768.9M+9.5%	$790.3M+12.5%	$687.4M-6.0%
Long-Term Debt	$563.5M-2.6%	$569.1M-3.2%	$560.0M-7.9%	$569.1M+4.9%	$578.5M+5.3%	$588.1M+5.7%	$608.2M+8.0%	$542.6M-4.8%
Total Equity	$1.3B-3.3%	$1.3B-6.4%	$1.2B-8.9%	$1.2B-11.1%	$1.4B+4.1%	$1.4B+5.9%	$1.4B+6.5%	$1.3B+7.1%
Retained Earnings	$1.1B+15.5%	$1.1B+10.5%	$1.0B+7.0%	$978.7M+5.0%	$965.3M+5.9%	$964.1M+9.3%	$970.7M+9.9%	$932.2M+11.2%

Not reported in any period shown, so not listed: Accounts Receivable.

ANDE Cash Flow Statement

ANDE quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$321.9M	$177.0M-46.6%	$331.5M-65.0%	$946.8M+229.7%	$287.1M+662.4%	-$51.0M+31.4%	-$74.4M-121.4%	$348.6M+1081.3%	-$35.5M-147.2%	$75.3M+90.2%	$39.6M-74.3%	$154.1M+1630.5%	-$10.1M-103.0%	$337.2M+2.7%	$328.5M+13.2%	$290.3M
Depreciation & Amortization	N/A	$133.3M+4.3%	$127.8M+2.2%	$125.1M-7.2%	$134.7M-24.7%	$178.9M-5.1%	$188.6M+29.1%	$146.2M+61.9%	$90.3M+4.5%	$86.4M+2.5%	$84.3M+7.5%	$78.5M+26.5%	$62.0M+12.1%	$55.3M+12.9%	$49.0M+19.9%	$40.8M
Stock-Based Compensation	N/A	$17.0M+24.6%	$13.6M+6.0%	$12.9M+14.9%	$11.2M+1.4%	$11.0M+8.4%	$10.2M-37.3%	$16.2M+145.0%	$6.6M+8.6%	$6.1M-12.7%	$7.0M+267.9%	$1.9M-77.9%	$8.6M+97.8%	$4.3M+8.7%	$4.0M-2.0%	$4.1M
Capital Expenditures	$265.0M	$233.1M+56.3%	$149.2M-0.8%	$150.4M+38.9%	$108.3M+42.9%	$75.8M-1.8%	$77.1M-53.3%	$165.2M+15.9%	$142.6M+312.1%	$34.6M-55.5%	$77.7M+7.3%	$72.5M+21.4%	$59.7M+27.5%	$46.8M-32.5%	$69.3M+56.9%	$44.2M
Free Cash Flow	$56.9M	-$56.1M-130.8%	$182.3M-77.1%	$796.3M+345.3%	$178.8M+241.0%	-$126.8M+16.3%	-$151.6M-182.7%	$183.3M+202.9%	-$178.1M-537.8%	$40.7M+206.6%	-$38.2M-146.7%	$81.7M+217.1%	-$69.7M-124.0%	$290.4M+12.0%	$259.2M+5.3%	$246.1M
Investing Cash Flow	-$242.9M	-$195.3M-19.8%	-$163.1M-6.0%	-$153.9M-190.9%	-$52.9M-110.9%	$487.2M+661.6%	-$86.8M+73.3%	-$325.0M-74.8%	-$186.0M-63.9%	-$113.5M-302.2%	-$28.2M+88.2%	-$238.5M-165.8%	-$89.7M+15.5%	-$106.3M+63.4%	-$290.6M-237.9%	-$86.0M
Financing Cash Flow	-$362.4M	-$447.1M-78.6%	-$250.4M+5.2%	-$264.0M+21.1%	-$334.7M-34.6%	-$248.8M-282.5%	$136.3M+1465.4%	$8.7M-95.8%	$209.2M+1892.6%	$10.5M+184.1%	-$12.5M-137.4%	$33.4M+135.3%	-$94.6M-57.5%	-$60.1M-175.2%	$79.9M+137.5%	-$213.1M
Dividends Paid	$27.1M	$26.8M+2.2%	$26.3M+3.5%	$25.4M+3.1%	$24.6M+3.6%	$23.7M+3.2%	$23.0M+4.0%	$22.1M+18.7%	$18.6M+2.7%	$18.2M+4.6%	$17.4M+9.1%	$15.9M+27.5%	$12.5M+4.2%	$12.0M+7.3%	$11.2M+37.0%	$8.2M
Share Buybacks	N/A	$15.4M+569.5%	$2.3M+31.4%	$1.7M-86.3%	$12.7M	$0	$0	N/A	N/A	$0	$0-100.0%	$49.1M	$0	$0	$0-100.0%	$3.0M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$487.9M+63.0%	-$393.7M-12.5%	-$6.2M-102.3%	$233.9M+11174.0%	$299.3M-1.7%	-$350.0M-46.1%	$268.8M+7.2%	-$2.1M-100.4%
Depreciation & Amortization	$34.6M+4.7%	$34.1M-0.7%	$33.3M-8.1%	$32.6M+7.4%	$33.1M+9.3%	$34.3M+11.0%	$36.2M+15.6%	$30.4M+22.1%
Capital Expenditures	$75.6M+54.8%	$51.7M+11.1%	$70.9M+26.7%	$66.8M+76.6%	$48.8M+70.6%	$46.5M+73.8%	$56.0M+34.1%	$37.8M+12.2%
Free Cash Flow	$412.4M+64.6%	-$445.4M-12.3%	-$77.1M-136.2%	$167.0M+518.1%	$250.5M-9.2%	-$396.6M-48.9%	$212.9M+1.9%	-$40.0M-108.8%
Investing Cash Flow	-$73.8M-131.5%	-$49.5M-12.9%	-$68.0M+6.2%	-$51.6M-59.0%	-$31.9M+11.7%	-$43.8M-98.8%	-$72.5M-98.0%	-$32.5M+28.8%
Financing Cash Flow	-$420.0M-205.6%	$417.8M+728.2%	$90.8M+203.5%	-$451.0M-956.9%	-$137.5M-535.0%	$50.4M+151.3%	-$87.8M-840.4%	-$42.7M+64.7%
Dividends Paid	$6.8M+1.8%	$6.8M+2.3%	$7.0M+2.2%	$6.5M+0.8%	$6.7M+3.0%	$6.7M+2.7%	$6.8M+3.1%	$6.5M+3.7%
Share Buybacks	N/A	N/A	$0-100.0%	$14.2M	N/A	N/A	$2.3M	N/A

Not reported in any period shown, so not listed: Stock-Based Compensation.

ANDE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ANDE quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	6.5%+0.3pp	6.2%+1.1pp	5.1%+1.1pp	4.0%-0.8pp	4.7%+0.2pp	4.5%-1.2pp	5.8%-4.2pp	9.9%+1.3pp	8.6%-0.2pp	8.8%-0.2pp	8.9%+0.2pp	8.8%+2.2pp	6.5%-0.3pp	6.8%-0.9pp	7.7%
Net Margin	0.9%-0.1pp	1.0%+0.3pp	0.7%-0.1pp	0.8%-0.1pp	0.8%+0.7pp	0.1%-0.1pp	0.2%-1.1pp	1.4%+0.2pp	1.1%+0.9pp	0.3%+0.6pp	-0.3%-2.7pp	2.4%+0.8pp	1.6%+0.1pp	1.5%-0.6pp	2.1%
Return on Equity	7.7%-0.7pp	8.3%+0.5pp	7.9%-3.0pp	10.9%+1.2pp	9.7%+8.9pp	0.8%-1.1pp	1.9%-3.1pp	5.0%-0.2pp	5.2%+3.7pp	1.5%+3.2pp	-1.7%-15.4pp	13.7%+0.8pp	12.8%-0.6pp	13.4%-4.8pp	18.1%
Return on Assets	2.6%-0.2pp	2.8%+0.1pp	2.6%-0.2pp	2.8%+0.6pp	2.3%+2.1pp	0.2%-0.3pp	0.5%-1.3pp	1.7%-0.2pp	2.0%+1.4pp	0.5%+1.1pp	-0.5%-5.2pp	4.6%+0.7pp	4.0%+0.3pp	3.6%-1.8pp	5.5%
Current Ratio	1.41-0.2x	1.65-0.1x	1.72+0.3x	1.370.0x	1.37+0.1x	1.25-0.1x	1.35+0.1x	1.23-0.1x	1.350.0x	1.32+0.1x	1.27+0.1x	1.220.0x	1.23-0.1x	1.31-0.1x	1.39
Debt-to-Equity	0.450.0x	0.450.0x	0.440.0x	0.41-0.1x	0.56-0.4x	0.92-0.1x	1.04+0.4x	0.60+0.1x	0.510.0x	0.51-0.1x	0.57+0.2x	0.37-0.2x	0.53-0.2x	0.72+0.3x	0.46
Asset Turnover	2.97+0.2x	2.73-1.1x	3.83+0.1x	3.76+1.0x	2.76+0.9x	1.89-0.2x	2.05+0.8x	1.27-0.4x	1.70-0.1x	1.760.0x	1.78-0.1x	1.92-0.5x	2.470.0x	2.42-0.2x	2.64
FCF Margin	-0.5%-2.1pp	1.6%-3.8pp	5.4%+4.4pp	1.0%+2.0pp	-1.0%+0.9pp	-1.9%-4.2pp	2.3%+8.1pp	-5.9%-7.0pp	1.1%+2.1pp	-1.0%-2.9pp	1.9%+3.5pp	-1.5%-6.7pp	5.2%+0.3pp	4.9%-0.5pp	5.4%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	7.2%+2.2pp	6.1%+0.4pp	9.1%+2.3pp	6.4%-0.4pp	5.1%-1.2pp	5.8%+1.0pp	6.8%0.0pp	6.8%+2.4pp
Net Margin	1.8%+1.6pp	1.3%+1.3pp	2.7%+1.2pp	0.8%-0.3pp	0.3%-1.0pp	0.0%-0.2pp	1.4%-0.2pp	1.0%+0.8pp
Return on Equity	4.3%+3.7pp	2.6%+2.6pp	5.4%+2.1pp	1.7%-0.3pp	0.6%-2.2pp	0.0%-0.4pp	3.3%-0.7pp	2.1%+1.3pp
Return on Assets	1.6%+1.4pp	0.9%+0.8pp	1.8%+0.7pp	0.6%-0.2pp	0.2%-0.9pp	0.0%-0.2pp	1.1%-0.2pp	0.8%+0.5pp
Current Ratio	1.51-0.5x	1.37-0.4x	1.41-0.2x	1.47-0.5x	2.01-0.1x	1.76-0.3x	1.65-0.1x	1.98+0.2x
Debt-to-Equity	0.430.0x	0.450.0x	0.450.0x	0.48+0.1x	0.420.0x	0.430.0x	0.450.0x	0.41-0.1x
Asset Turnover	0.890.0x	0.670.0x	0.68-0.1x	0.810.0x	0.91+0.1x	0.70-0.1x	0.76-0.1x	0.77-0.2x
FCF Margin	13.3%+5.3pp	-17.0%-2.0pp	-3.0%-9.9pp	6.2%+7.8pp	8.0%-1.9pp	-14.9%-5.1pp	6.8%+0.3pp	-1.5%-14.0pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Andersons Inc/The ANDE	FY2025	$11.0B	$95.7M	0.9%	$2.2B	23/100
United Natural Foods Inc UNFI	FY2026	$31.2B	$84.0M	0.3%	$2.9B	31/100
Mission Produce, Inc. AVO	FY2025	$1.4B	$37.7M	2.7%	$1.1B	55/100
SpartanNash Company SPTN	FY2024	$9.5B	$299K	0.0%	$910.9M	37/100
Calavo Growers Inc CVGW	FY2025	$648.4M	$19.8M	3.0%	$466.3M	50/100
The Chef's Warehouse Inc CHEF	FY2025	$4.1B	$72.4M	1.7%	$4.6B	48/100

Where Andersons Inc/The Ranks

Frequently Asked Questions

What is Andersons Inc/The's annual revenue?

Andersons Inc/The (ANDE) reported $11.0B in total revenue for fiscal year 2025. This represents a -2.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Andersons Inc/The's revenue growing?

Andersons Inc/The (ANDE) revenue declined by 2.2% year-over-year, from $11.3B to $11.0B in fiscal year 2025.

Is Andersons Inc/The profitable?

Yes, Andersons Inc/The (ANDE) reported a net income of $95.7M in fiscal year 2025, with a net profit margin of 0.9%.

How much debt does Andersons Inc/The have?

As of fiscal year 2025, Andersons Inc/The (ANDE) had $98.3M in cash and equivalents against $560.0M in long-term debt.

What is Andersons Inc/The's gross margin?

Andersons Inc/The (ANDE) had a gross margin of 6.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Andersons Inc/The's net profit margin?

Andersons Inc/The (ANDE) had a net profit margin of 0.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Andersons Inc/The pay dividends?

Yes, Andersons Inc/The (ANDE) paid $0.79 per share in dividends during fiscal year 2025.

What is Andersons Inc/The's return on equity (ROE)?

Andersons Inc/The (ANDE) has a return on equity of 7.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Andersons Inc/The's free cash flow?

Andersons Inc/The (ANDE) recorded an outflow of $56.1M in free cash flow during fiscal year 2025. This represents a -130.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Andersons Inc/The's operating cash flow?

Andersons Inc/The (ANDE) generated $177.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Andersons Inc/The's total assets?

Andersons Inc/The (ANDE) had $3.7B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Andersons Inc/The's capital expenditures?

Andersons Inc/The (ANDE) invested $233.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Andersons Inc/The buy back shares?

Yes, Andersons Inc/The (ANDE) spent $15.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Andersons Inc/The have outstanding?

Andersons Inc/The (ANDE) had 34M shares outstanding as of fiscal year 2025.

What is Andersons Inc/The's current ratio?

Andersons Inc/The (ANDE) had a current ratio of 1.41 as of fiscal year 2025, which is considered adequate.

What is Andersons Inc/The's debt-to-equity ratio?

Andersons Inc/The (ANDE) had a debt-to-equity ratio of 0.45 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Andersons Inc/The's return on assets (ROA)?

Andersons Inc/The (ANDE) had a return on assets of 2.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Andersons Inc/The's P/E ratio?

Andersons Inc/The (ANDE) trades at 12.4x earnings, its market capitalization divided by net income of $177.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $2.2B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Andersons Inc/The's price-to-sales ratio?

Andersons Inc/The (ANDE) trades at 0.2x sales, its market capitalization divided by revenue of $10.9B revenue, trailing 12 months to June 30, 2026. The market capitalization is $2.2B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Andersons Inc/The's Piotroski F-Score?

Andersons Inc/The (ANDE) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Andersons Inc/The's earnings high quality?

Andersons Inc/The (ANDE) has an earnings quality ratio of 1.85x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Andersons Inc/The?

Andersons Inc/The (ANDE) scores 23 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.